Oncogen-GOF |
|
USMLE |
2017-02-02 |
Cdmac91 |
12 |
0 |
edit |
|
TSG Path |
|
USMLE |
2017-02-10 |
Cdmac91 |
16 |
0 |
edit |
|
3 expansion-genetics |
3 expansion-genetics |
USMLE |
2017-02-21 |
Cdmac91 |
4 |
0 |
edit |
|
Viral-micro |
Viral-micro |
USMLE |
2017-02-21 |
Cdmac91 |
7 |
0 |
edit |
|
General pharm |
G-protein linked second messengers |
USMLE |
2017-02-21 |
Cdmac91 |
17 |
0 |
edit |
|
Stack #2456704 |
Direct agonists, indirect agonists |
Unfinished |
2017-02-21 |
Cdmac91 |
10 |
0 |
edit |
|
M antagonist |
M antagonist |
USMLE |
2017-02-21 |
Cdmac91 |
8 |
0 |
edit |
|
sympathomimetics |
Direct, indirect sympathomimetics |
USMLE |
2017-02-21 |
Cdmac91 |
14 |
0 |
edit |
|
alpha blockers |
nonselective, alpha 1 selective , alpha 2 selective |
USMLE |
2017-02-21 |
Cdmac91 |
4 |
0 |
edit |
|
Beta blockers |
selective and nonselective beta blockers |
USMLE |
2017-02-21 |
Cdmac91 |
6 |
0 |
edit |
|
Seafood toxins |
Seafood toxins |
USMLE |
2017-02-21 |
Cdmac91 |
3 |
0 |
edit |
|
Toxicities |
Toxicities and side effects |
USMLE |
2017-02-21 |
Cdmac91 |
22 |
0 |
edit |
|
Cyt P450 |
inducers, substrates, inhibitors |
USMLE |
2017-02-21 |
Cdmac91 |
23 |
0 |
edit |
|
Drug interactions |
Drug interactions |
USMLE |
2017-02-21 |
Cdmac91 |
4 |
0 |
edit |
|
Cardic drugs |
Cardic drugs |
USMLE |
2017-02-26 |
Cdmac91 |
26 |
0 |
edit |
|